Literature DB >> 23786380

Synthesis and in vitro photodynamic activity of oligomeric ethylene glycol-quinoline substituted zinc(II) phthalocyanine derivatives.

Xiao Jia1, Feng-Feng Yang, Jun Li, Jian-Yong Liu, Jin-Ping Xue.   

Abstract

A new series of zinc(II) phthalocyanine derivatives have been synthesized and characterized. These macrocycles exhibited a sharp absorption band in the red visible region in DMF, which indicated that they were dissolved well and almost did not aggregate in this solvent. Compared with the unsubstituted zinc(II) phthalocyanine, all these phthalocyanines have a red-shifted Q-band (at 678-699 vs 670 nm) and exhibit a relatively weaker fluorescence emission and a higher efficiency at generating singlet oxygen. The monosubstituted photosensitizers also exhibit high photocytotoxicity toward HepG2 human hepatocarcinoma cells with IC50 values as low as 0.02-0.05 μM (λ = 670 nm, 80 mW·cm(-2), 1.5 J·cm(-2)). The high photodynamic activities of these compounds are in accordance with their low aggregation tendency and high cellular uptake. Their structure-activity relationship was assessed by determining the photophysical properties, cellular uptake, and in vitro photodynamic activities of this series of compounds. As shown by confocal microscopy, monosubstituted phthalocyanines can target the mitochondria and lysosomes of the cells, and tetrasubstituted phthalocyanines tend to target the lysosomes of the cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23786380     DOI: 10.1021/jm400722d

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

1.  Effect of tertiary amino groups in the hydrophobic segment of an amphiphilic block copolymer on zinc phthalocyanine encapsulation and photodynamic activity.

Authors:  Makoto Obata; Eika Ishihara; Shiho Hirohara
Journal:  RSC Adv       Date:  2022-06-21       Impact factor: 4.036

Review 2.  Use of Cyclodextrins in Anticancer Photodynamic Therapy Treatment.

Authors:  Amina Ben Mihoub; Ludivine Larue; Albert Moussaron; Zahraa Youssef; Ludovic Colombeau; Francis Baros; Céline Frochot; Régis Vanderesse; Samir Acherar
Journal:  Molecules       Date:  2018-08-02       Impact factor: 4.411

3.  Synthesis and antitumor mechanism of a new iron(iii) complex with 5,7-dichloro-2-methyl-8-quinolinol as ligands.

Authors:  Bi-Qun Zou; Qi-Pin Qin; Yu-Xia Bai; Qian-Qian Cao; Ye Zhang; Yan-Cheng Liu; Zhen-Feng Chen; Hong Liang
Journal:  Medchemcomm       Date:  2017-02-01       Impact factor: 3.597

4.  Synthesis, crystal structure, cytotoxicity and action mechanism of a Rh(iii) complex with 8-hydroxy-2-methylquinoline as a ligand.

Authors:  Yun-Liang Zhang; Qi-Pin Qin; Qian-Qian Cao; Hong-Hua Han; Zhu-Ling Liu; Yan-Cheng Liu; Hong Liang; Zhen-Feng Chen
Journal:  Medchemcomm       Date:  2016-10-25       Impact factor: 3.597

5.  Eighteen 5,7-Dihalo-8-quinolinol and 2,2'-Bipyridine Co(II) Complexes as a New Class of Promising Anticancer Agents.

Authors:  Ting Meng; Qi-Pin Qin; Hua-Hong Zou; Kai Wang; Fu-Pei Liang
Journal:  ACS Med Chem Lett       Date:  2019-10-30       Impact factor: 4.345

6.  Ligand substituent effect on the cytotoxicity activity of two new copper(ii) complexes bearing 8-hydroxyquinoline derivatives: validated by MTT assay and apoptosis in MCF-7 cancer cell line (human breast cancer).

Authors:  Arif Ali; Somesh Banerjee; Saima Kamaal; Mohammad Usman; Neeladrisingha Das; Mohd Afzal; Abdullah Alarifi; Nayim Sepay; Partha Roy; Musheer Ahmad
Journal:  RSC Adv       Date:  2021-04-16       Impact factor: 3.361

7.  Low-Dose Near-Infrared Light-Activated Mitochondria-Targeting Photosensitizers for PDT Cancer Therapy.

Authors:  Wenyu Wu Klingler; Nadine Giger; Lukas Schneider; Vipin Babu; Christiane König; Patrick Spielmann; Roland H Wenger; Stefano Ferrari; Bernhard Spingler
Journal:  Int J Mol Sci       Date:  2022-08-23       Impact factor: 6.208

Review 8.  An updated overview on the development of new photosensitizers for anticancer photodynamic therapy.

Authors:  Juan Zhang; Chengshi Jiang; João Paulo Figueiró Longo; Ricardo Bentes Azevedo; Hua Zhang; Luis Alexandre Muehlmann
Journal:  Acta Pharm Sin B       Date:  2017-09-22       Impact factor: 11.413

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.